Spotlight on Clinical Trials
In recent years, there has been a concerning rise in breast cancer diagnoses in young women (under age 50) in the United States. Although breast cancer is more commonly diagnosed in older women, more young women are being diagnosed, and some with aggressive tumors that require complex treatments. This is why clinical trials are especially […]
Complementary therapies are one of the most popular and rapidly growing options to help relieve some of the side effects of breast cancer treatment or the cancer itself. In fact, a recent national survey showed that 73% of breast cancer patients in the U.S. reported using at least one type of complementary therapy after their […]
Despite important advances in breast cancer treatment, the disease can still find ways to outsmart even the best therapies. People living with HER2-positive metastatic breast cancer (HER2+ MBC) often respond well to treatments at first, with tumors shrinking or slowing down, but the effectiveness of these drugs doesn’t always last. Through the EmpowHER-303 clinical trial […]
Vaccines to prevent breast cancer from occurring, recurring or spreading are being studied in clinical trials across the U.S. and we are shining a spotlight on a few that are focused on these vaccines. This new, exciting area of research has the potential to advance care for people who are at high risk of breast […]
Mammograms have been considered the gold standard for breast cancer screening for decades, but today’s mammogram screening recommendations don’t always offer a personalized approach. Today, most women may begin screenings at age 40, regardless of unique personal factors like ethnicity, family history or breast density. Researchers are exploring new ways to personalize breast cancer screening […]
The beginning of a new year brings hope for clinical trials, because it often means the start of new research, new discoveries and new advancements that may help to improve the lives of patients.
Breast cancer is often thought of as a disease that primarily affects women, but men also have a small amount of breast tissue, which means they can get breast cancer too. In the U.S., approximately one in every 100 breast cancer cases is diagnosed in a man. An estimated 2,790 men in the U.S. will […]
Research has shown that exercise can improve overall survival, treatment tolerability and quality of life for women with early-stage breast cancer. But what about women who are living with metastatic breast cancer (MBC)? Through a clinical trial, researchers are exploring whether the addition of exercise to standard treatment could hold promise for women living with […]
Researchers are always seeking safer, more effective treatment options for breast cancer patients through clinical trials, with the hope that these new treatments could also be more tolerable. For people living with metastatic estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer, the hormone therapy fulvestrant is the standard treatment for […]
For breast cancer researchers, one of the biggest goals of a clinical trial is to address the unmet needs of people living with advanced breast cancer. Advanced breast cancer is difficult to cure or control with treatment. The cancer may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body, i.e. bones, lungs, brain, or liver. Patients with advanced breast cancer need more treatment options.
“In the Black community, there’s a stigma about treatment, clinical trials and research. We have to understand that there’s not enough data to help us if we get sick. There’s not enough data to create treatments that will help us. We need to participate in clinical trials.” Sharon Elmore-Anderson Patient Advocate Living with Metastatic IBC
